Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Array Biopharma Inc (NASDAQ:ARRY)

10.92
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
6.73
Today|||52-Week Range
13.40
+24.23%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
AssetsCash68.6M55.7M56.6M125.9M
 
 
 
 
 
Short Term Investment Cash7.9M-12.9M907.0K69.3M
 
 
 
 
 
Cash & Short Term Investments111.0M178.3M109.9M234.3M
 
 
 
 
 
 
ReceivablesReceivables5.4M6.3M39.3M31.3M
 
 
 
 
 
 
InventoriesInventories----0.000.00--
 
Current AssetsOther Current Assets5.2M6.4M6.1M4.6M
 
 
 
 
 
Current Assets121.7M191.0M155.3M270.2M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross90.4M58.4M60.3M63.6M
 
 
 
 
 
Depreciation-82.3M-53.4M-53.6M-55.5M
 
 
 
 
 
Other Assets8.6M1.6M6.3M104.0K
 
 
 
 
 
Total Assets139.1M198.2M168.9M279.1M
 
 
 
 
 
 
LiabilitiesAccounts Payable7.0M4.6M10.1M8.6M
 
 
 
 
 
Accrued Expenses11.5M20.1M20.2M33.0M
 
 
 
 
 
Other Current Liabilities37.6M30.3M33.7M50.7M
 
 
 
 
 
Other Liabilities52.7M42.4M52.4M69.6M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt104.0M107.3M113.7M133.9M
 
 
 
 
 
Other Liabilities640.0K496.0K4.8M6.6M
 
 
 
 
 
Total Liabilities164.8M155.6M206.8M267.4M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity-25.7M42.7M-37.9M11.7M
 
 
 
 
 
Total Shareholder Equity-25.7M42.7M-37.9M11.7M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding131.8M142.1M143.7M171.3M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.